HELP     Sign In
Search

Relevance to Autism

Evaluation of the clinical data from 41 patients with congenital disorder of glycosylation, type Ic, mediated by ALG6 mutations (ALG6-CDG) found that behavioral problems or mood disorders occurred in 14 patients, with most of these 14 patients showing autistic features. Furthermore, five patients with ALG6-CDG were diagnosed with autism (Morava et al., 2016).

Molecular Function

This gene encodes a member of the ALG6/ALG8 glucosyltransferase family that catalyzes the addition of the first glucose residue to the growing lipid-linked oligosaccharide precursor of N-linked glycosylation. Mutations in this gene are associated with congenital disorder of glycosylation, type Ic (CDG1C; OMIM 603147), a multisystem disorder resulting in a wide variety of clinical features, including developmental delay, hypotonia, epilepsy, ataxia, and failure to thrive.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies.
Congenital disorder of glycosylation, type Ic
ASD or autistic features
Support
Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability
ID, epilepsy/seizures

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN830R001a 
 missense_variant 
 c.998C>T 
 p.Ala333Val 
 Familial 
 Both parents 
  

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
1
Deletion-Duplication
 24
 
1
Deletion
 3
 
1
Deletion
 1
 
1
Duplication
 4
 
1
Deletion
 1
 
1
Duplication
 1
 

No Animal Model Data Available

 

No Interactions Available
HELP
Copyright © 2017 MindSpec, Inc.